TwinStrand Biosciences

About:

TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.

Website: http://www.twinstrandbio.com

Twitter/X: twinstrandbio

Top Investors: Madrona, Alexandria Venture Investments, Section 32, Janus Henderson Investors, Ridgeback Capital

Description:

TwinStrand Biosciences improves the accuracy of DNA sequencing by >10,000 fold and allows detection of mutations that are invisible by other approaches, through its technology. Its technology, Duplex Sequencing, is based on research and has potential applications in a wide range of fields, including oncology, infectious disease, organ transplantation, reproductive and genetic health, and forensics.

Total Funding Amount:

$83.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)twinstrandbio.com

Founders:

Jesse Salk

Number of Employees:

11-50

Last Funding Date:

2023-06-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai